Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of .beta.APP
US5721130A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | May 12, 1995 |
| Grant date | Feb 24, 1998 |
| Priority date | — |
| Expiry date | May 12, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Processing of .beta.-amyloid precursor protein (.beta.APP) is monitored by detecting the secretion of a soluble .beta.APP fragment resulting from cleavage of .beta.APP at the amino-terminus of .beta.-amyloid peptide. In vivo monitoring of secretion of the .beta.APP fragment may be monitored for diagnosis and prognosis of Alzheimer's disease and other .beta.-amyloid-related diseases, while in vitro monitoring of such secretion from cultured cells may be monitored to identify inhibitors of .beta.-amyloid production. The .beta.APP fragment may be detected using antibodies and other specific binding substances which recognize a carboxy-terminal residue on the fragment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.